201 related articles for article (PubMed ID: 31462227)
1. NPM1 as a potential therapeutic target for atypical teratoid/rhabdoid tumors.
Phi JH; Sun CH; Lee SH; Lee S; Park I; Choi SA; Park SH; Lee JY; Wang KC; Kim SK; Yun H; Park CK
BMC Cancer; 2019 Aug; 19(1):848. PubMed ID: 31462227
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor.
Suzuki M; Kondo A; Ogino I; Arai H; Tomita T; Sredni ST
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 27966820
[TBL] [Abstract][Full Text] [Related]
3. Description of a new oncogenic mechanism for atypical teratoid rhabdoid tumors in patients with ring chromosome 22.
Byers HM; Adam MP; LaCroix A; Leary SE; Cole B; Dobyns WB; Mefford HC
Am J Med Genet A; 2017 Jan; 173(1):245-249. PubMed ID: 27734605
[TBL] [Abstract][Full Text] [Related]
4. Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis.
Torchia J; Picard D; Lafay-Cousin L; Hawkins CE; Kim SK; Letourneau L; Ra YS; Ho KC; Chan TS; Sin-Chan P; Dunham CP; Yip S; Ng HK; Lu JQ; Albrecht S; Pimentel J; Chan JA; Somers GR; Zielenska M; Faria CC; Roque L; Baskin B; Birks D; Foreman N; Strother D; Klekner A; Garami M; Hauser P; Hortobágyi T; Bognár L; Wilson B; Hukin J; Carret AS; Van Meter TE; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheineman K; Johnston D; Michaud J; Zelcer S; Hammond R; Ramsay DA; Fleming AJ; Lulla RR; Fangusaro JR; Sirachainan N; Larbcharoensub N; Hongeng S; Barakzai MA; Montpetit A; Stephens D; Grundy RG; Schüller U; Nicolaides T; Tihan T; Phillips J; Taylor MD; Rutka JT; Dirks P; Bader GD; Warmuth-Metz M; Rutkowski S; Pietsch T; Judkins AR; Jabado N; Bouffet E; Huang A
Lancet Oncol; 2015 May; 16(5):569-82. PubMed ID: 25882982
[TBL] [Abstract][Full Text] [Related]
5. Recurrent atypical teratoid/rhabdoid tumors (AT/RT) reveal discrete features of progression on histology, epigenetics, copy number profiling, and transcriptomics.
Johann PD; Altendorf L; Efremova EM; Holsten T; Steinbügl M; Nemes K; Eckhardt A; Kresbach C; Bockmayr M; Koch A; Haberler C; Antonelli M; DeSisto J; Schuhmann MU; Hauser P; Siebert R; Bens S; Kool M; Green AL; Hasselblatt M; Frühwald MC; Schüller U
Acta Neuropathol; 2023 Sep; 146(3):527-541. PubMed ID: 37450044
[TBL] [Abstract][Full Text] [Related]
6. Integrated genomics has identified a new AT/RT-like yet INI1-positive brain tumor subtype among primary pediatric embryonal tumors.
Ho DM; Shih CC; Liang ML; Tsai CY; Hsieh TH; Tsai CH; Lin SC; Chang TY; Chao ME; Wang HW; Wong TT
BMC Med Genomics; 2015 Jun; 8():32. PubMed ID: 26109171
[TBL] [Abstract][Full Text] [Related]
7. Frequent overexpression of HMGA2 in human atypical teratoid/rhabdoid tumor and its correlation with let-7a3/let-7b miRNA.
Zhang K; Gao H; Wu X; Wang J; Zhou W; Sun G; Wang J; Wang Y; Mu B; Kim C; Chu P; Ho DM; Ann DK; Wong TT; Yen Y
Clin Cancer Res; 2014 Mar; 20(5):1179-89. PubMed ID: 24423609
[TBL] [Abstract][Full Text] [Related]
8. Transposable element insertion as a mechanism of SMARCB1 inactivation in atypical teratoid/rhabdoid tumor.
Thomas C; Oehl-Huber K; Bens S; Soschinski P; Koch A; Nemes K; Oyen F; Kordes U; Kool M; Frühwald MC; Hasselblatt M; Siebert R
Genes Chromosomes Cancer; 2021 Aug; 60(8):586-590. PubMed ID: 33896072
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of osteopontin gene in atypical teratoid/rhabdoid tumor of the central nervous system.
Kao CL; Chiou SH; Chen YJ; Singh S; Lin HT; Liu RS; Lo CW; Yang CC; Chi CW; Lee CH; Wong TT
Mod Pathol; 2005 Jun; 18(6):769-78. PubMed ID: 15776015
[TBL] [Abstract][Full Text] [Related]
10. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
11. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
[TBL] [Abstract][Full Text] [Related]
12. Maternal embryonal leucine zipper kinase immunoreactivity in atypical teratoid/rhabdoid tumors: a study of 50 cases.
Ravindra N; Rao S; Arivazhagan A; Santosh V
Childs Nerv Syst; 2021 Dec; 37(12):3769-3775. PubMed ID: 34611764
[TBL] [Abstract][Full Text] [Related]
13. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
[TBL] [Abstract][Full Text] [Related]
14. Molecular Transition of an Adult Low-Grade Brain Tumor to an Atypical Teratoid/Rhabdoid Tumor Over a Time-Course of 14 Years.
Schweizer Y; Meszaros Z; Jones DTW; Koelsche C; Boudalil M; Fiesel P; Schrimpf D; Piro RM; Brehmer S; von Deimling A; Kerl U; Seiz-Rosenhagen M; Capper D
J Neuropathol Exp Neurol; 2017 Aug; 76(8):655-664. PubMed ID: 28789476
[TBL] [Abstract][Full Text] [Related]
15. Identification of Hub Genes in Atypical Teratoid/Rhabdoid Tumor by Bioinformatics Analyses.
Pan X; Liu W; Chai Y; Hu L; Wang J; Zhang Y
J Mol Neurosci; 2020 Nov; 70(11):1906-1913. PubMed ID: 32440821
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
[TBL] [Abstract][Full Text] [Related]
17. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors.
Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y
Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280
[TBL] [Abstract][Full Text] [Related]
18. Atypical teratoid/rhabdoid tumor with retained INI1 (SMARCB1) expression and loss of BRG1 (SMARCA4).
Bookhout C; Bouldin TW; Ellison DW
Neuropathology; 2018 Jun; 38(3):305-308. PubMed ID: 29271065
[TBL] [Abstract][Full Text] [Related]
19. Adult Atypical Teratoid/Rhabdoid Tumors.
Wu WW; Bi WL; Kang YJ; Ramkissoon SH; Prasad S; Shih HA; Reardon DA; Dunn IF
World Neurosurg; 2016 Jan; 85():197-204. PubMed ID: 26344637
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation.
Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J
J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
